Table 1. Clinical characteristics of the 17 HIV-1-infected patients.

	Age		VL(copies/ml)							CD4+T cell counts(cells/ul)
NO.	(years)	ART	w0	w4	w12	w24	w60	Sex	Tr	w0	w4	w8	w12	w24	w48	w60
1	42	AZT+3TC+NVP	6158	41	44	<40	<40	M	Ho	25	117	190	187	174	190	265
2	29	D4T+3TC+NVP	24185	533	62	118	44	M	Ho	244	210	187	231	330	308	257
3	32	D4T+3TC+NVP	5089	352	<40	73	<40	F	ND	248	302	417	385	394	412	532
4	31	D4T+3TC+NVP	68639	43701	ND	133	<40	M	Ho	196	416	294	302	322	407	380
5	33	AZT+3TC+NVP	48808	1490	341	<40	<40	M	Ho	159	204	251	233	205	418	290
6	41	D4T+3TC+NVP	397739	1034	735	59	47	M	Ho	341	400	320	228	334	524	535
7	37	D4T+3TC+NVP	1837	257	<40	<40	<40	M	Ho	249	205	306	336	354	384	368
8	36	D4T+3TC+NVP	8016	113	<40	<40	<40	M	Ho	227	366	366	344	411	271	363
9	30	D4T+3TC+NVP	20206	130	<40	<40	45	M	Ho	116	232	234	136	250	355	371
10	27	D4T+3TC+NVP	41811	836	179	<40	<40	M	Ho	267	319	416	473	373	378	490
11	28	AZT+3TC+NVP	10416	288	46	71	<40	M	Ho	237	228	260	331	208	350	425
12	38	D4T+3TC+NVP	1528	3503	1435	ND	<40	F	He	215	216	235	201	251	247	234
13	29	D4T+3TC+NVP	67897	1126	134	<40	<40	M	Ho	190	224	333	270	350	390	341
14	28	D4T+3TC+NVP	46227	295	<40	<40	<40	M	Ho	322	308	280	302	290	414	303
15	26	D4T+3TC+NVP	20977	578	104	45	<40	M	Ho	66	169	160	193	258	186	170
16	42	D4T+3TC+NVP	58578	1655	150	266	<40	M	Ho	124	203	230	285	269	288	310
17	30	D4T+3TC+NVP	46746	130	140	<40	<40	M	Ho	34	29	28	41	100	192	167
Median	31		24185	533 **	83 **	<40 **	<40 **			215	224 **	260 **	270 **	290 **	355 **	341 **

ART, antiretroviral therapy; AZT, zidovudine; 3TC, lamivudine; NVP, nevirapine; d4T, stavudine; F, female; M,male; ND, not determined; Tr: transmission route; Ho: homosexual; He: heterosexual;

^** p<0.01, compared to week 0.